Fatigue in Parkinson’s disease—A narrative review
Authors:
Open Access
- 1 September 2024
- journal article
- Published by Wolters Kluwer Health in Annals of Movement Disorders
- Vol. 7 (3) , 157-170
Abstract
Although fatigue is a common non-motor symptom of Parkinson’s disease (PD), it is often overlooked during routine assessments of individuals with PD. This can be attributed partly to the lack of recognition of this symptom and the coexistence of other confounding symptoms, such as apathy, somnolence, and depression. However, considering the effects of fatigue on the quality of life (QoL) of individuals with PD, it is crucial to review its causes and management strategies. According to the diagnostic criteria for PD-related fatigue, patients must report significantly reduced energy levels or an increased perception of effort disproportionate to their attempted activities. PD-related fatigue can be divided into central and peripheral types. Peripheral fatigue involves muscle weakness and impaired voluntary movements, influenced by tremors and bradykinesia. Central fatigue, which can be divided into mental and physical subtypes, manifests as persistent exhaustion without peripheral motor deficits. The pathophysiology of central fatigue in PD is complex. It involves dysfunction in the striato–limbic–serotonergic system, imbalance of neurotransmitters (dopamine and serotonin), as well as hypoconnectivity in the supplementary motor area and hyperconnectivity in the default mode network. Emerging evidence suggests that neuroinflammation and autonomic dysfunction may contribute to fatigue. Fatigue in PD is treated using pharmacological therapies (such as dopaminergic agents, antidepressants, methylphenidate, and modafinil) and non-pharmacological interventions (such as exercise). There is a gap in the current understanding, measurement, and treatment of fatigue in PD. A deeper understanding of the patho-mechanisms of fatigue in PD is needed to establish evidence-based treatment guidelines. The QoL of individuals with PD can be improved by focusing on person-centered interventions targeting fatigue.Keywords
This publication has 100 references indexed in Scilit:
- Management of Depression in Parkinson's Disease: A Systematic ReviewMovement Disorders Clinical Practice, 2017
- Fatigue in Parkinson's disease: The contribution of cerebral metabolic changesHuman Brain Mapping, 2016
- Treatment of Fatigue in Parkinson DiseaseJAMA, 2016
- The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic ManagementMovement Disorders Clinical Practice, 2016
- CYTOKINE TARGETS IN THE BRAIN: IMPACT ON NEUROTRANSMITTERS AND NEUROCIRCUITSDepression and Anxiety, 2013
- Fatigue in Parkinson's disease: A reviewMovement Disorders, 2006
- A Controlled Trial of Rotigotine Monotherapy in Early Parkinson's DiseaseArchives of Neurology, 2003
- Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover studyMovement Disorders, 2003
- Exacerbated physical fatigue and mental fatigue in Parkinson's diseaseMovement Disorders, 2001
- The Fatigue Severity ScaleArchives of Neurology, 1989